Orlance

Developer of a platform to deliver nucleic acid vaccines and related therapies

placeSeattle, Washington, United States calendar_todayFounded 2016 language orlance.com

1 investor on record.

Investor type	Count	Share
Other / undisclosed	1	100%

Coming soon